¼¼°èÀÇ EDTA(Ethylenediamine Tetraacetic Acid) Æ©ºê ½ÃÀå
Ethylenediamine Tetraacetic Acid (EDTA) Tubes
»óǰÄÚµå : 1797277
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 371 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ EDTA(Ethylenediamine Tetraacetic Acid) Æ©ºê ½ÃÀåÀº 2030³â±îÁö 29¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 21¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ EDTA(Ethylenediamine Tetraacetic Acid) Æ©ºê ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 5.5%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 29¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®µÇ°í ÀÖ´Â ºÎ¹®ÀÇ ÇϳªÀÎ K2 EDTA Tube´Â CAGR 4.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 17¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. K3 EDTA Æ©ºê ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 7.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5¾ï 7,570¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ EDTA(Ethylenediamine Tetraacetic Acid) Æ©ºê ½ÃÀåÀº 2024³â¿¡ 5¾ï 7,570¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 5¾ï 8,060¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£2024-2030³â CAGRÀº 8.5%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.8%¿Í 5.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ EDTA(Ethylenediamine Tetraacetic Acid) Æ©ºê ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

EDTA Æ©ºê°¡ Çö´ë Áø´Ü ¹× ÀÓ»ó ½ÇÇè½Ç¿¡¼­ ÇʼöÀûÀÎ °ÍÀ¸·Î °£ÁֵǴ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¿¡Æ¿·»µð¾Æ¹Î Åׯ®¶ó ¾Æ¼¼Æ®»ê(EDTA) Æ©ºê´Â Ç×ÀÀ°íÁ¦·Î¼­ EDTA¸¦ »çÀü ÄÚÆÃÇÑ ÀϹÝÀûÀΠäÇ÷¿ë±âÀÔ´Ï´Ù. EDTA´Â Ä®½· À̿°ú È¿°úÀûÀ¸·Î °áÇÕÇÏ¿© Ç÷Àü Çü¼ºÀ» ¹æÁöÇϰí Ç÷±¸ ÇüŸ¦ À¯ÁöÇϹǷΠÇ÷¾×ÇÐ °Ë»ç¿¡ ÇʼöÀûÀÎ Æ©ºêÀÔ´Ï´Ù. ÀüÇ÷±¸°è»ê(CBC), Ç÷¾×Çü °Ë»ç, ºÐÀÚÁø´Ü, DNA¿Í RNA¸¦ ÀÌ¿ëÇÑ °¢Á¾ °Ë»ç¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

Ç÷¾× Áø´ÜÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀº äÃëµÈ °ËüÀÇ ¹«°á¼º¿¡ Å©°Ô Á¿ìµË´Ï´Ù. EDTA Æ©ºê´Â äÃë ÈÄ ¸î ½Ã°£ µ¿¾È ¼¼Æ÷ ±¸Á¶¸¦ À¯ÁöÇÏ¿© ¹éÇ÷±¸, ÀûÇ÷±¸, Ç÷¼ÒÆÇ, ÇÙ»êÀÇ Á¤È®ÇÑ ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. º´¿ø, Áø´Ü ½ÇÇè½Ç, Ç÷¾× ÀºÇà, ¿¬±¸½Ã¼³¿¡¼­ ³Î¸® »ç¿ëµÇ´Â EDTA Æ©ºê´Â ÀÏ»óÀûÀÌ°í Æ¯¼öÇÑ ½ÇÇè½Ç ¿öÅ©Ç÷ο쿡 ÇʼöÀûÀÎ Á¦Ç°ÀÔ´Ï´Ù.

EDTA Æ©ºêÀÇ »õ·Î¿î ¼ÒÀç¿Í µðÀÚÀÎ °³¼±Àº ¹«¾ùÀΰ¡?

Á¦Á¶¾÷ü´Â Àç·áÀÇ Ç°Áú, Æó¼â ½Ã½ºÅÛ, Ç×ÀÀ°íÁ¦ ¹èÇÕÀÇ °³¼±À» ÅëÇØ EDTA Æ©ºê¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ´ëºÎºÐÀÇ Æ©ºê´Â À¯¸® ¶Ç´Â ÇÃ¶ó½ºÆ½(Æú¸®¿¡Æ¿·» Å×·¹ÇÁÅ»·¹ÀÌÆ® ¶Ç´Â Æú¸®ÇÁ·ÎÇÊ·»)À¸·Î ¸¸µé¾îÁö¸ç, ÆÄ¼Õ À§Çè °¨¼Ò¿Í °æ·®È­·Î ÀÎÇØ ÇÃ¶ó½ºÆ½ÀÌ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ ±â¼ú·Î´Â ½ºÅ©·ù ĸ, ¾ÈÀü ĸ, ¿À¿° ¾ø´Â äÃë ¹× Ã³¸®¸¦ º¸ÀåÇÏ´Â Áø°ø ¹ÐºÀ ¼³°è µîÀÌ ÀÖ½À´Ï´Ù.

ºÐ¹« °ÇÁ¶ ¶Ç´Â ¾×ü EDTAÀÇ ±ÕÀÏÇÑ ÄÚÆÃÀº ÀϰüµÈ Ç×ÀÀ°í È¿°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ÁÖ·Î ¶óº¥´õ»ö, º¸¶ó»ö µî »ö»óÀ¸·Î ±¸ºÐµÈ ĸÀº ½ÇÇè½Ç¿¡¼­ ½Å¼ÓÇÑ ½Äº°À» ¿ëÀÌÇÏ°Ô Çϱâ À§ÇØ Áö¿ªº°·Î Ç¥ÁØÈ­µÇ¾î ÀÖ½À´Ï´Ù. ÀϺΠÁ¦Á¶¾÷ü´Â ¹ÙÄÚµå ¶óº§, ¿ë·® Ç¥½Ã±â, RFID ĨÀ» ³»ÀåÇÏ¿© ÃßÀû ¹× ½Ã·á Ãë±ÞÀ» °³¼±Çϰí ÀÖ½À´Ï´Ù. °Ö ¼¼ÆÛ·¹ÀÌÅÍ, ÀÀ°í Ȱ¼ºÈ­Á¦ µîÀÇ Ã·°¡Á¦ ¶ÇÇÑ Æ¯Á¤ ÀÌ¿ë »ç·Ê¸¦ À§ÇØ °ËÅäµÇ°í ÀÖÀ¸¸ç, ´Ù¾çÇÑ Áø´Ü¿¡¼­ ½Ã·áÀÇ Ç°ÁúÀ» Çâ»ó½Ã۱â À§ÇØ °ËÅäµÇ°í ÀÖ½À´Ï´Ù.

¼ö¿ä´Â ¾îµð·Î È®´ëµÇ°í, ÇÙ½É ÃÖÁ¾»ç¿ëÀÚ´Â?

EDTA Æ©ºê¿¡ ´ëÇÑ ¼ö¿ä´Â Àü ¼¼°è¿¡¼­ Áø´Ü ½Ã¼ú Áõ°¡¿Í ¸¸¼ºÁúȯ ¹× °¨¿°¼º ÁúȯÀÇ ºÎ´ã Áõ°¡·Î ÀÎÇØ ¼ö¿ä°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÇÙ½É »ç¿ëÀÚ´Â ÀÓ»ó°Ë»ç½Ç, º´¿ø, º´¸®°Ë»ç½Ç, Ç÷¾×ÀºÇà, ¹ÙÀÌ¿À¹ðÅ©, Çмú¿¬±¸¼¾ÅÍ µîÀÔ´Ï´Ù. ¿¹¹æ°ËÁø, ¸ÂÃãÀÇ·á, °¨¿°º´ °Ë»çÀÇ ±Þ°ÝÇÑ ¼ºÀåµµ äÇ÷ ºóµµ¸¦ Áõ°¡½ÃÄÑ Æ©ºê »ç¿ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

°¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â ½ÃÀåÀ¸·Î´Â ºÏ¹Ì¿Í À¯·´ÀÌ ÀÖÀ¸¸ç, ÷´Ü ÀÇ·á ÀÎÇÁ¶ó¿Í ÀÚµ¿ Ç÷¾× ºÐ¼®±âÀÇ ÀÏ»óÀûÀÎ »ç¿ëÀ¸·Î Áö¿øµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áø´Ü ³×Æ®¿öÅ©ÀÇ È®Àå, µµ½Ã Áö¿ªÀÇ ÀÇ·á Á¢±Ù¼º, °Ë»ç½Ç ÀÚµ¿È­¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­´Â °øÁß º¸°Ç Áø´ÜÀ» À§ÇÑ Á¤ºÎ ÇÁ·Î±×·¥ÀÌ Ç¥ÁØÈ­µÈ äÇ÷ ½Ã½ºÅÛ Á¶´Þ Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

EDTA Æ©ºê ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

EDTA Æ©ºê ½ÃÀåÀÇ ¼ºÀåÀº ¼¼°è Áø´Ü·® Áõ°¡, Ç÷¾× ±â¹Ý Áúº´ °Ë»ç¿¡ ´ëÇÑ °ü½É Áõ°¡, ÀÓ»ó ½ÇÇè½Ç È®Àå µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. äÇ÷ ½Ã½ºÅÛÀÇ ±â¼úÀû °³¼±, ÀÚµ¿ ºÐ¼®±â¿ÍÀÇ È£È¯¼º Çâ»ó, Ç×ÀÀ°íÁ¦ÀÇ ¾ÈÁ¤¼º Çâ»óÀ¸·Î Á¦Ç°ÀÇ °ü·Ã¼ºÀÌ °­È­µÇ¾ú½À´Ï´Ù.

ºÐÀÚÁø´Ü, ¾Ï À¯ÀüüÇÐ, Áý´Ü °Ç°­ Á¶»ç¿¡¼­ ÃÖÁ¾ ¿ëµµ°¡ È®´ëµÊ¿¡ µû¶ó EDTA º¸Á¸ Ç÷¾× »ùÇÿ¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀçÅÃÁø´Ü°ú ÇöÀåÁø´Ü(Point of Care) °Ë»çÀÇ ¼ºÀåµµ ÈÞ´ë°¡ °¡´ÉÇÏ°í ¾ÈÀüÇÑ Ã¤Ç÷ ±â±âÀÇ ±â¼ú Çõ½ÅÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø ½Ã½ºÅÛÀÌ Áø´Ü Áß½ÉÀÌ µÇ°í ½ÇÇè½ÇÀÇ ÀÚµ¿È­°¡ ÁøÇàµÊ¿¡ µû¶ó EDTA Æ©ºê´Â ÀÓ»ó °Ëü °ü¸®ÀÇ ±âº» ¿ä¼Ò·Î ³²À» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

À¯Çü(K2 EDTA Æ©ºê, K3 EDTA Æ©ºê), ¿ëµµ(¿ÏÀü Ç÷±¸ °è¼ö ¿ëµµ, Ç÷¾× µµ¸» ¿ëµµ, ÀÀ°í °Ë»ç ¿ëµµ, °ñ¼ö »ý°Ë ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø ÃÖÁ¾ ¿ëµµ, Áø´Ü ¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, ¿¬±¸°³¹ß ¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market to Reach US$2.9 Billion by 2030

The global market for Ethylenediamine Tetraacetic Acid (EDTA) Tubes estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. K2 EDTA Tube, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the K3 EDTA Tube segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$575.7 Million While China is Forecast to Grow at 8.5% CAGR

The Ethylenediamine Tetraacetic Acid (EDTA) Tubes market in the U.S. is estimated at US$575.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$580.6 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Ethylenediamine Tetraacetic Acid (EDTA) Tubes Market - Key Trends & Drivers Summarized

Why Are EDTA Tubes Considered Essential in Modern Diagnostic and Clinical Laboratories?

Ethylenediamine tetraacetic acid (EDTA) tubes are commonly used blood collection containers pre-coated with EDTA as an anticoagulant. These tubes are critical for hematology tests because EDTA effectively binds calcium ions, preventing clot formation and preserving blood cell morphology. They are widely used for complete blood counts (CBC), blood typing, molecular diagnostics, and various DNA or RNA-based tests.

The precision and reliability of blood-based diagnostics heavily depend on the integrity of the collected specimen. EDTA tubes maintain cellular structure for hours after collection, enabling accurate analysis of white and red blood cells, platelets, and nucleic acids. Their widespread use across hospitals, diagnostic labs, blood banks, and research facilities makes them indispensable in routine and specialized laboratory workflows.

What Are the Emerging Material and Design Improvements in EDTA Tubes?

Manufacturers are refining EDTA tubes through improvements in material quality, closure systems, and anticoagulant formulations. Most tubes are made of glass or plastic (polyethylene terephthalate or polypropylene), with plastic variants gaining preference due to their reduced breakage risk and lighter weight. Innovations include screw caps, safety closures, and vacuum-sealed designs to ensure contamination-free collection and processing.

Uniform coating of spray-dried or liquid EDTA ensures consistent anticoagulant action. Color-coded caps, primarily lavender or purple, are standardized across regions to facilitate quick identification in labs. Some manufacturers are integrating barcode labels, volume indicators, and RFID chips for improved tracking and sample handling. Additions such as gel separators or clot activators are also being explored for specific use cases, enhancing sample quality across diverse diagnostics.

Where Is Demand Expanding, and Who Are the Core End-Users?

EDTA tube demand is expanding globally due to the increasing number of diagnostic procedures and the rising burden of chronic and infectious diseases. Core users include clinical laboratories, hospitals, pathology labs, blood banks, biobanks, and academic research centers. Rapid growth in preventive screening, personalized medicine, and infectious disease testing has also increased the frequency of blood draws, thereby fueling tube usage.

High-volume markets include North America and Europe, supported by advanced healthcare infrastructure and routine use of automated hematology analyzers. Asia Pacific is witnessing strong growth due to expanding diagnostic networks, urban healthcare access, and rising investments in laboratory automation. In emerging markets, government programs for public health diagnostics are contributing to increased procurement of standardized blood collection systems.

What Is Driving Growth in the EDTA Tubes Market?

Growth in the EDTA tubes market is driven by several factors including rising global diagnostic volumes, increased focus on blood-based disease screening, and the expanding reach of clinical laboratories. Technological improvements in blood collection systems, enhanced compatibility with automated analyzers, and better anticoagulant stability are reinforcing product relevance.

End-use expansion in molecular diagnostics, cancer genomics, and population health studies is increasing reliance on EDTA-preserved blood samples. Growth in home diagnostics and point-of-care testing is also supporting innovation in portable and safe blood collection devices. As healthcare delivery systems become more diagnostic-centered and lab automation increases, EDTA tubes will continue to be a foundational element of clinical sample management.

SCOPE OF STUDY:

The report analyzes the Ethylenediamine Tetraacetic Acid (EDTA) Tubes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (K2 EDTA Tube, K3 EDTA Tube); Application (Complete Blood Count Application, Blood Smear Application, Coagulation Tests Application, Bone Marrow Biopsy Application, Other Applications); End-Use (Hospitals End-Use, Diagnostics Centers End-Use, R&D Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â